| 000 | 01622 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250513035643.0 | ||
| 264 | 0 | _c19951011 | |
| 008 | 199510s 0 0 eng d | ||
| 022 | _a0090-3493 | ||
| 024 | 7 |
_a10.1097/00003246-199509000-00011 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aStack, A M | |
| 245 | 0 | 0 |
_aFailure of prophylactic and therapeutic use of a murine anti-tumor necrosis factor monoclonal antibody in Escherichia coli sepsis in the rabbit. _h[electronic resource] |
| 260 |
_bCritical care medicine _cSep 1995 |
||
| 300 |
_a1512-8 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntibodies, Monoclonal _xtherapeutic use |
| 650 | 0 | 4 |
_aBicarbonates _xblood |
| 650 | 0 | 4 | _aBlood Pressure |
| 650 | 0 | 4 | _aDisease Models, Animal |
| 650 | 0 | 4 | _aDrug Evaluation, Preclinical |
| 650 | 0 | 4 |
_aEscherichia coli Infections _xdrug therapy |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aPeritonitis _xdrug therapy |
| 650 | 0 | 4 | _aProspective Studies |
| 650 | 0 | 4 | _aRabbits |
| 650 | 0 | 4 | _aRandom Allocation |
| 650 | 0 | 4 |
_aSepsis _xdrug therapy |
| 650 | 0 | 4 | _aSurvival Analysis |
| 650 | 0 | 4 |
_aTumor Necrosis Factor-alpha _ximmunology |
| 700 | 1 | _aSaladino, R A | |
| 700 | 1 | _aThompson, C | |
| 700 | 1 | _aSattler, F | |
| 700 | 1 | _aWeiner, D L | |
| 700 | 1 | _aParsonnet, J | |
| 700 | 1 | _aNariuchi, H | |
| 700 | 1 | _aSiber, G R | |
| 700 | 1 | _aFleisher, G R | |
| 773 | 0 |
_tCritical care medicine _gvol. 23 _gno. 9 _gp. 1512-8 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1097/00003246-199509000-00011 _zAvailable from publisher's website |
| 999 |
_c7663984 _d7663984 |
||